Latest News for: rapt

Edit

(DCS) Building Resilience for Lifelong Success - RAPT Microsoft Teams (State of Indiana)

Public Technologies 22 Jan 2026
). Building Resilience for Lifelong Success. 6 Credits. Thursday, January 22, 9am-4pm Eastern. Microsoft Teams.
Edit

RAPT Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process ...

Business Wire 22 Jan 2026
... LLC (“KSF”) are investigating the proposed sale of RAPT Therapeutics, Inc ... RAPT) to GSK plc (NYSE.
Edit

Halper Sadeh LLC Encourages CVGW, RAPT, CFLT Shareholders to Contact the Firm to Discuss Their Rights

PR Newswire 21 Jan 2026
NEW YORK, Jan ... Calavo Growers, Inc. (NASDAQ ... RAPT Therapeutics, Inc. (NASDAQ. RAPT)'s sale to GSK plc for $58.00 per share. If you are a RAPT shareholder, click here to learn more about your legal rights and options. Confluent, Inc. (NASDAQ ... 21% ... .
Edit

RAPT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of RAPT Therapeutics, Inc. ...

Image Caledonian Record 20 Jan 2026
NEW YORK--(BUSINESS WIRE)--Jan 20, 2026-- ....
Edit

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of RAPT Therapeutics, Inc. (NASDAQ: RAPT)

PR Newswire 20 Jan 2026
The firm is headquartered at the Empire State Building in New York City and is investigating RAPT Therapeutics, Inc ... RAPT) related to its sale to GSK plc ... Click here for more info https.//monteverdelaw.com/case/rapt-therapeutics-inc/.
Edit

GSK to buy RAPT Therapeutics for $2.2 billion

Hong Kong Standard 20 Jan 2026
GSK will buy RAPT Therapeutics for ...
Edit

GSK to buy RAPT Therapeutics for US$2.2 billion

Hong Kong Standard 20 Jan 2026
GSK will buy RAPT Therapeutics for ...
Edit

GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments

Wall Street Journal 20 Jan 2026
The drugmaker said it agreed to pay RAPT Therapeutics shareholders $58 per share, with $1.9 billion upfront investment in cash ... .
Edit

British pharmaceutical company GSK acquires American Rapt Therapeutics for $2.2 billion

AK&M Information Agency 20 Jan 2026
British pharmaceutical company GSK acquires American Rapt Therapeutics for $2.2 billion . AKM.RU ....
Edit

Forbion Announces Second Exit from Forbion Growth Fund III Following $2.2 Billion Acquisition of RAPT ...

Nasdaq Globe Newswire 20 Jan 2026
... RAPT Therapeutics, Inc ... RAPT) in a transaction valued at $2.2 billion.
Edit

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq ...

Nasdaq Globe Newswire 20 Jan 2026
BALA CYNWYD, Pa., Jan ... .
Edit

RAPT Therapeutics stock surges 63% in pre-market trade on Nasdaq after GSK's $2.2 billion acquisition deal

Live Mint 20 Jan 2026
RAPT Therapeutics' stock jumped more than 63% during ...
Edit

Shareholder Alert: The Ademi Firm investigates whether RAPT Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders

PR Newswire 20 Jan 2026
20, 2026 /PRNewswire/ -- Ademi LLP is investigating RAPT (NASDAQ. RAPT) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with GSK plc ... RAPT ...
Edit

GSK enters agreement to acquire RAPT Therapeutics (Form 8-K) (Rapt Therapeutics Inc)

Public Technologies 20 Jan 2026
GSK enters agreement to acquire RAPT Therapeutics • ... GSK) today announced that it has entered a definitive agreement to acquire RAPT Therapeutics ("RAPT") (NASDAQ ... Brian Wong, President & Chief Executive Officer, RAPT Therapeutics, said.
Edit

GSK to buy RAPT Therapeutics in $2.2 billion deal for promising food allergy therapy

The Economic Times 20 Jan 2026
Britain's GSK is set to acquire RAPT Therapeutics for $2.2 billion ... .

Article Search

tools
×
×
×
×